Literature DB >> 27058936

Uncertain Oversight of Regenerative Medicines in Japan under the ASRM.

Tamra Lysaght1, Shigeki Sugii2.   

Abstract

Mesh：

Year:  2016        PMID： 27058936     DOI： 10.1016/j.stem.2016.03.007

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


× No keyword cloud information.
  3 in total

Review 1.  Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations.

Authors:  Tamra Lysaght; Ian H Kerridge; Douglas Sipp; Gerard Porter; Benjamin J Capps
Journal:  J Bioeth Inq       Date:  2017-02-28       Impact factor: 1.352

Review 2.  Adoption of Regulations for Cell Therapy Development: Linkage Between Taiwan and Japan.

Authors:  Teng-Huang Tsai; Thai-Yen Ling; Chung-Hsi Lee
Journal:  Clin Transl Sci       Date:  2020-06-07       Impact factor: 4.689

Review 3.  Reflection on the enactment and impact of safety laws for regenerative medicine in Japan.

Authors:  Kayo Takashima; Michael Morrison; Jusaku Minari
Journal:  Stem Cell Reports       Date:  2021-05-20       Impact factor: 7.765
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.